Zhenyang Su

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Coronary Artery

Cardiovascular Risk Factors

Left Ventricular

Top Venues

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Luyang Wang, Anning Du, Yan Lu, Yunxi Zhao, Ming Qiu, Zhenyang Su, Huanyu Shu, Hui Shen, Wei Sun, Xiangqing Kong
Peptidase Inhibitor 16 Attenuates Left Ventricular Injury and Remodeling After Myocardial Infarction by Inhibiting the HDAC1-Wnt3a-β-Catenin Signaling Axis. Journal of the American Heart Association 12 (10) (2023)
Luyang Wang, Anning Du, Yan Lu, Yunxi Zhao, Ming Qiu, Zhenyang Su, Huanyu Shu, Hui Shen, Wei Sun, Xiangqing Kong
Peptidase Inhibitor 16 Attenuates Left Ventricular Injury and Remodeling After Myocardial Infarction by Inhibiting the HDAC1-Wnt3a-β-Catenin Signaling Axis. Journal of the American Heart Association 12 (10) (2023)
Luyang Wang, Anning Du, Yan Lu, Yunxi Zhao, Ming Qiu, Zhenyang Su, Huanyu Shu, Hui Shen, Wei Sun, Xiangqing Kong
Peptidase Inhibitor 16 Attenuates Left Ventricular Injury and Remodeling After Myocardial Infarction by Inhibiting the HDAC1-Wnt3a-β-Catenin Signaling Axis. Journal of the American Heart Association 12 (10) (2023)
Luyang Wang, Anning Du, Yan Lu, Yunxi Zhao, Ming Qiu, Zhenyang Su, Huanyu Shu, Hui Shen, Wei Sun, Xiangqing Kong
Peptidase Inhibitor 16 Attenuates Left Ventricular Injury and Remodeling After Myocardial Infarction by Inhibiting the HDAC1-Wnt3a-β-Catenin Signaling Axis. Journal of the American Heart Association (2023)
Luyang Wang, Anning Du, Yan Lu, Yunxi Zhao, Ming Qiu, Zhenyang Su, Huanyu Shu, Hui Shen, Wei Sun, Xiangqing Kong
Peptidase Inhibitor 16 Attenuates Left Ventricular Injury and Remodeling After Myocardial Infarction by Inhibiting the HDAC1-Wnt3a-β-Catenin Signaling Axis. Journal of the American Heart Association 12 (10) (2023)